# Slate Medicines, Inc. — Form D

Slate Medicines, Inc. of BOSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2026-03-11. The offering totals $130.0M, of which $10.0M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2026-03-11
- Form: D
- Accession: 0001231919-26-000246
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $130.0M
- Amount sold: $10.0M
- Remaining: $120.0M
- Investors: 6
- Date of first sale: 2026-02-17
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-576090

## Issuer

- Name: Slate Medicines, Inc.
- CIK: 0002117806
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2024
- Address: 200 BERKELEY STREET, 18TH FLOOR, BOSTON, MA, 02116
- Phone: (617) 778-2500

## Officers, directors & promoters (7)

| Name | Role | Location |
| --- | --- | --- |
| Neil Buckley | Director | Boston, MA |
| Andrew Levin | Director | BOSTON, MA |
| Tim Lohoff | Director | Boston, MA |
| Cindy Xiong | Director | Boston, MA |
| Neil Buckley | Executive Officer | Boston, MA |
| Gregory Frank Oakes | Executive Officer | Boston, MA |
| Sara Pacheco | Executive Officer | Boston, MA |

## More

- [CIK 2117806 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2117806&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001231919-26-000246.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.